Skip to main content

Table 3 Classification of patients grouped by NLR < 2.27 (low-NLR-Group) and NLR ≥2.27 (high-NLR-Group)

From: Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma

  Low-NLR-Group (n = 47) High-NLR-Group (n = 32) P-value
Age (years)
 < 61 28 (60%) 10 (31%) 0.021*
 ≥ 61 19 (40%) 22 (69%)
Gender (male) 26 (55%) 21 (66%) 0.48
Myasthenia gravis 8 (17%) 7 (22%) 0.77
WBC (× 109/L) 7.0 8.1 0.09
Neoadjuvant therapy 2 (4%) 1 (3%) 0.79
Adjuvant radiotherapy 29 (62%) 18 (56%) 0.65
WHO classification
 A 3 (6%) 2 (6%) 0.39
 AB 15 (32%) 17 (53%)
 B1 12 (26%) 4 (13%)
 B2 7 (15%) 4 (13%)
 B3 10 (21%) 5 (15%)
Masaoka-Koga stage
 I 12 (26%) 9 (28%) 0.68
 II 23 (49%) 18 (56%)
 III 11 (23%) 5 (16%)
 IV 1 (2%) 0 (0%)
TNM stage
 I 37 (79%) 28 (88%) 0.028*
 II 0 (0%) 2 (6%)
 IIIA 10 (21%) 1 (3%)
 IIIB 0 (0%) 1 (3%)
  1. Significant data are marked (*)